ASHM Report Back
Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.
Mind the gap: Progress towards treatment for all and its impact on prevention
Treatment as prevention - if we treated everyone as soon as they became infected, they would not be infectious and over time HIV would go away.
Where are we with our 90-90-90 UNAIDS targets?
This equates to 27 million people on ARVs globally.
Currently we are about 40% of that number.
Testing is difficult for countries like Australia and the UK.
Countries show large variability in the proportion of those on treatment.
Less variability by country in viral suppression of those on treatment.
Treatment guidelines are also inconsistent across the globe, where not everyone has adopted treatment for all.
There is lots of data missing from countries, and this is very basic surveillance data.
About 20,000 undiagnosed in UK, uptake of testing is poor.
3,000 new infections per year, would be reduced to 1,000 if we met our 90% diagnosed target.